Serena Koenig

Internal Medicine

Credentials: · · ·

History

LANCET-HBV: Hepatitis B Infection in the Era of Long-Acting ART
National Institute of Allergy and Infectious Diseases · R01
PI · $673.2K · University of California Los Angeles
2026–2031
PRESCIENT: A Phase IIc, Open-Label, Randomized Controlled Trial of Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $5.9M · Brigham and Women's Hospital
2022–2027
A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed with HIV
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.7M · Brigham and Women's Hospital
2017–2021
Immediate Fast-Track Versus Standard Care for Persons Living with HIV in Haiti: A Randomized Pilot Study
National Institute of Mental Health · R34
Contact PI · $547.6K · Brigham and Women's Hospital
2018–2020

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis
Principal investigator · Active not recruiting · Phase 2
Brigham and Women's Hospital
2023–2027
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Principal investigator · Unknown · Phase 4
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
2020–2022
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
Principal investigator · Unknown
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
2020–2022
Immediate Fast-Track Versus Standard Care for Persons Living With HIV in Haiti
Principal investigator · Completed
Brigham and Women's Hospital
2018–2021